Baillie Gifford Health Innovation Equities Fund Class K (BGHDX) is a Health fund with $15.42 Million in assets. The fund allocates 37.79% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Alnylam Pharmaceuticals Inc at 7.11% of total assets. This is followed by Moderna Inc (3.72%) and Argenx SE (7.58%).